Home Healthcare Pharmaceuticals Glaucoma Treatment Market

Glaucoma Treatment Market Size, Share & Trends Analysis Report By Disease Type (Open Angle Glaucoma, Angle Closure Glaucoma, Other), By Drug Class (Prostaglandin Analog, Beta Blockers, Adrenergic Agonist, Carbonic Anhydrase Inhibitors, Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: May 25, 2026 | Author: Debashree B | Format:
Overview TOC Segmentation Methodology
Download Free Sample

Market Segmentation

  1. Glaucoma Treatment Market, By Disease Type 2022-2034 (USD MILLION/ Units)
    1. Open Angle Glaucoma
    2. Angle Closure Glaucoma
    3. Other
  2. Glaucoma Treatment Market, By Drug Class 2022-2034 (USD MILLION/ Units)
    1. Prostaglandin Analog
    2. Beta Blockers
    3. Adrenergic Agonist
    4. Carbonic Anhydrase Inhibitors
    5. Others
  3. Glaucoma Treatment Market, By Distribution Channel 2022-2034 (USD MILLION/ Units)
    1. Hospital Pharmacy
    2. Retail Pharmacy
    3. Online Pharmacy
  4. Regional Glaucoma Treatment Market
    1. North America
      1. North America Glaucoma Treatment Market By Disease Type 2022-2034 (USD MILLION/ Units)
        1. Open Angle Glaucoma
        2. Angle Closure Glaucoma
        3. Other
      2. North America Glaucoma Treatment Market By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Prostaglandin Analog
        2. Beta Blockers
        3. Adrenergic Agonist
        4. Carbonic Anhydrase Inhibitors
        5. Others
      3. North America Glaucoma Treatment Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacy
        2. Retail Pharmacy
        3. Online Pharmacy
      4. U.S.
        1. Open Angle Glaucoma
        2. Angle Closure Glaucoma
        3. Other
        4. Prostaglandin Analog
        5. Beta Blockers
        6. Adrenergic Agonist
        7. Carbonic Anhydrase Inhibitors
        8. Others
        9. Hospital Pharmacy
        10. Retail Pharmacy
        11. Online Pharmacy
      5. Canada
        1. Open Angle Glaucoma
        2. Angle Closure Glaucoma
        3. Other
        4. Prostaglandin Analog
        5. Beta Blockers
        6. Adrenergic Agonist
        7. Carbonic Anhydrase Inhibitors
        8. Others
        9. Hospital Pharmacy
        10. Retail Pharmacy
        11. Online Pharmacy
    2. Europe
      1. Europe Glaucoma Treatment Market By Disease Type 2022-2034 (USD MILLION/ Units)
        1. Open Angle Glaucoma
        2. Angle Closure Glaucoma
        3. Other
      2. Europe Glaucoma Treatment Market By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Prostaglandin Analog
        2. Beta Blockers
        3. Adrenergic Agonist
        4. Carbonic Anhydrase Inhibitors
        5. Others
      3. Europe Glaucoma Treatment Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacy
        2. Retail Pharmacy
        3. Online Pharmacy
      4. U.K.
        1. Open Angle Glaucoma
        2. Angle Closure Glaucoma
        3. Other
        4. Prostaglandin Analog
        5. Beta Blockers
        6. Adrenergic Agonist
        7. Carbonic Anhydrase Inhibitors
        8. Others
        9. Hospital Pharmacy
        10. Retail Pharmacy
        11. Online Pharmacy
      5. Germany
        1. Open Angle Glaucoma
        2. Angle Closure Glaucoma
        3. Other
        4. Prostaglandin Analog
        5. Beta Blockers
        6. Adrenergic Agonist
        7. Carbonic Anhydrase Inhibitors
        8. Others
        9. Hospital Pharmacy
        10. Retail Pharmacy
        11. Online Pharmacy
      6. France
        1. Open Angle Glaucoma
        2. Angle Closure Glaucoma
        3. Other
        4. Prostaglandin Analog
        5. Beta Blockers
        6. Adrenergic Agonist
        7. Carbonic Anhydrase Inhibitors
        8. Others
        9. Hospital Pharmacy
        10. Retail Pharmacy
        11. Online Pharmacy
      7. Spain
        1. Open Angle Glaucoma
        2. Angle Closure Glaucoma
        3. Other
        4. Prostaglandin Analog
        5. Beta Blockers
        6. Adrenergic Agonist
        7. Carbonic Anhydrase Inhibitors
        8. Others
        9. Hospital Pharmacy
        10. Retail Pharmacy
        11. Online Pharmacy
      8. Italy
        1. Open Angle Glaucoma
        2. Angle Closure Glaucoma
        3. Other
        4. Prostaglandin Analog
        5. Beta Blockers
        6. Adrenergic Agonist
        7. Carbonic Anhydrase Inhibitors
        8. Others
        9. Hospital Pharmacy
        10. Retail Pharmacy
        11. Online Pharmacy
      9. Russia
        1. Open Angle Glaucoma
        2. Angle Closure Glaucoma
        3. Other
        4. Prostaglandin Analog
        5. Beta Blockers
        6. Adrenergic Agonist
        7. Carbonic Anhydrase Inhibitors
        8. Others
        9. Hospital Pharmacy
        10. Retail Pharmacy
        11. Online Pharmacy
      10. Nordic
        1. Open Angle Glaucoma
        2. Angle Closure Glaucoma
        3. Other
        4. Prostaglandin Analog
        5. Beta Blockers
        6. Adrenergic Agonist
        7. Carbonic Anhydrase Inhibitors
        8. Others
        9. Hospital Pharmacy
        10. Retail Pharmacy
        11. Online Pharmacy
      11. Benelux
        1. Open Angle Glaucoma
        2. Angle Closure Glaucoma
        3. Other
        4. Prostaglandin Analog
        5. Beta Blockers
        6. Adrenergic Agonist
        7. Carbonic Anhydrase Inhibitors
        8. Others
        9. Hospital Pharmacy
        10. Retail Pharmacy
        11. Online Pharmacy
      12. Rest of Europe
        1. Open Angle Glaucoma
        2. Angle Closure Glaucoma
        3. Other
        4. Prostaglandin Analog
        5. Beta Blockers
        6. Adrenergic Agonist
        7. Carbonic Anhydrase Inhibitors
        8. Others
        9. Hospital Pharmacy
        10. Retail Pharmacy
        11. Online Pharmacy
    3. APAC
      1. APAC Glaucoma Treatment Market By Disease Type 2022-2034 (USD MILLION/ Units)
        1. Open Angle Glaucoma
        2. Angle Closure Glaucoma
        3. Other
      2. APAC Glaucoma Treatment Market By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Prostaglandin Analog
        2. Beta Blockers
        3. Adrenergic Agonist
        4. Carbonic Anhydrase Inhibitors
        5. Others
      3. APAC Glaucoma Treatment Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacy
        2. Retail Pharmacy
        3. Online Pharmacy
      4. China
        1. Open Angle Glaucoma
        2. Angle Closure Glaucoma
        3. Other
        4. Prostaglandin Analog
        5. Beta Blockers
        6. Adrenergic Agonist
        7. Carbonic Anhydrase Inhibitors
        8. Others
        9. Hospital Pharmacy
        10. Retail Pharmacy
        11. Online Pharmacy
      5. Korea
        1. Open Angle Glaucoma
        2. Angle Closure Glaucoma
        3. Other
        4. Prostaglandin Analog
        5. Beta Blockers
        6. Adrenergic Agonist
        7. Carbonic Anhydrase Inhibitors
        8. Others
        9. Hospital Pharmacy
        10. Retail Pharmacy
        11. Online Pharmacy
      6. Japan
        1. Open Angle Glaucoma
        2. Angle Closure Glaucoma
        3. Other
        4. Prostaglandin Analog
        5. Beta Blockers
        6. Adrenergic Agonist
        7. Carbonic Anhydrase Inhibitors
        8. Others
        9. Hospital Pharmacy
        10. Retail Pharmacy
        11. Online Pharmacy
      7. India
        1. Open Angle Glaucoma
        2. Angle Closure Glaucoma
        3. Other
        4. Prostaglandin Analog
        5. Beta Blockers
        6. Adrenergic Agonist
        7. Carbonic Anhydrase Inhibitors
        8. Others
        9. Hospital Pharmacy
        10. Retail Pharmacy
        11. Online Pharmacy
      8. Australia
        1. Open Angle Glaucoma
        2. Angle Closure Glaucoma
        3. Other
        4. Prostaglandin Analog
        5. Beta Blockers
        6. Adrenergic Agonist
        7. Carbonic Anhydrase Inhibitors
        8. Others
        9. Hospital Pharmacy
        10. Retail Pharmacy
        11. Online Pharmacy
      9. Taiwan
        1. Open Angle Glaucoma
        2. Angle Closure Glaucoma
        3. Other
        4. Prostaglandin Analog
        5. Beta Blockers
        6. Adrenergic Agonist
        7. Carbonic Anhydrase Inhibitors
        8. Others
        9. Hospital Pharmacy
        10. Retail Pharmacy
        11. Online Pharmacy
      10. South East Asia
        1. Open Angle Glaucoma
        2. Angle Closure Glaucoma
        3. Other
        4. Prostaglandin Analog
        5. Beta Blockers
        6. Adrenergic Agonist
        7. Carbonic Anhydrase Inhibitors
        8. Others
        9. Hospital Pharmacy
        10. Retail Pharmacy
        11. Online Pharmacy
      11. Rest of Asia-Pacific
        1. Open Angle Glaucoma
        2. Angle Closure Glaucoma
        3. Other
        4. Prostaglandin Analog
        5. Beta Blockers
        6. Adrenergic Agonist
        7. Carbonic Anhydrase Inhibitors
        8. Others
        9. Hospital Pharmacy
        10. Retail Pharmacy
        11. Online Pharmacy
    4. Middle East and Africa
      1. Middle East and Africa Glaucoma Treatment Market By Disease Type 2022-2034 (USD MILLION/ Units)
        1. Open Angle Glaucoma
        2. Angle Closure Glaucoma
        3. Other
      2. Middle East and Africa Glaucoma Treatment Market By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Prostaglandin Analog
        2. Beta Blockers
        3. Adrenergic Agonist
        4. Carbonic Anhydrase Inhibitors
        5. Others
      3. Middle East and Africa Glaucoma Treatment Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacy
        2. Retail Pharmacy
        3. Online Pharmacy
      4. UAE
        1. Open Angle Glaucoma
        2. Angle Closure Glaucoma
        3. Other
        4. Prostaglandin Analog
        5. Beta Blockers
        6. Adrenergic Agonist
        7. Carbonic Anhydrase Inhibitors
        8. Others
        9. Hospital Pharmacy
        10. Retail Pharmacy
        11. Online Pharmacy
      5. Turkey
        1. Open Angle Glaucoma
        2. Angle Closure Glaucoma
        3. Other
        4. Prostaglandin Analog
        5. Beta Blockers
        6. Adrenergic Agonist
        7. Carbonic Anhydrase Inhibitors
        8. Others
        9. Hospital Pharmacy
        10. Retail Pharmacy
        11. Online Pharmacy
      6. Saudi Arabia
        1. Open Angle Glaucoma
        2. Angle Closure Glaucoma
        3. Other
        4. Prostaglandin Analog
        5. Beta Blockers
        6. Adrenergic Agonist
        7. Carbonic Anhydrase Inhibitors
        8. Others
        9. Hospital Pharmacy
        10. Retail Pharmacy
        11. Online Pharmacy
      7. South Africa
        1. Open Angle Glaucoma
        2. Angle Closure Glaucoma
        3. Other
        4. Prostaglandin Analog
        5. Beta Blockers
        6. Adrenergic Agonist
        7. Carbonic Anhydrase Inhibitors
        8. Others
        9. Hospital Pharmacy
        10. Retail Pharmacy
        11. Online Pharmacy
      8. Egypt
        1. Open Angle Glaucoma
        2. Angle Closure Glaucoma
        3. Other
        4. Prostaglandin Analog
        5. Beta Blockers
        6. Adrenergic Agonist
        7. Carbonic Anhydrase Inhibitors
        8. Others
        9. Hospital Pharmacy
        10. Retail Pharmacy
        11. Online Pharmacy
      9. Nigeria
        1. Open Angle Glaucoma
        2. Angle Closure Glaucoma
        3. Other
        4. Prostaglandin Analog
        5. Beta Blockers
        6. Adrenergic Agonist
        7. Carbonic Anhydrase Inhibitors
        8. Others
        9. Hospital Pharmacy
        10. Retail Pharmacy
        11. Online Pharmacy
      10. Rest of MEA
        1. Open Angle Glaucoma
        2. Angle Closure Glaucoma
        3. Other
        4. Prostaglandin Analog
        5. Beta Blockers
        6. Adrenergic Agonist
        7. Carbonic Anhydrase Inhibitors
        8. Others
        9. Hospital Pharmacy
        10. Retail Pharmacy
        11. Online Pharmacy
    5. LATAM
      1. LATAM Glaucoma Treatment Market By Disease Type 2022-2034 (USD MILLION/ Units)
        1. Open Angle Glaucoma
        2. Angle Closure Glaucoma
        3. Other
      2. LATAM Glaucoma Treatment Market By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Prostaglandin Analog
        2. Beta Blockers
        3. Adrenergic Agonist
        4. Carbonic Anhydrase Inhibitors
        5. Others
      3. LATAM Glaucoma Treatment Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacy
        2. Retail Pharmacy
        3. Online Pharmacy
      4. Brazil
        1. Open Angle Glaucoma
        2. Angle Closure Glaucoma
        3. Other
        4. Prostaglandin Analog
        5. Beta Blockers
        6. Adrenergic Agonist
        7. Carbonic Anhydrase Inhibitors
        8. Others
        9. Hospital Pharmacy
        10. Retail Pharmacy
        11. Online Pharmacy
      5. Mexico
        1. Open Angle Glaucoma
        2. Angle Closure Glaucoma
        3. Other
        4. Prostaglandin Analog
        5. Beta Blockers
        6. Adrenergic Agonist
        7. Carbonic Anhydrase Inhibitors
        8. Others
        9. Hospital Pharmacy
        10. Retail Pharmacy
        11. Online Pharmacy
      6. Argentina
        1. Open Angle Glaucoma
        2. Angle Closure Glaucoma
        3. Other
        4. Prostaglandin Analog
        5. Beta Blockers
        6. Adrenergic Agonist
        7. Carbonic Anhydrase Inhibitors
        8. Others
        9. Hospital Pharmacy
        10. Retail Pharmacy
        11. Online Pharmacy
      7. Chile
        1. Open Angle Glaucoma
        2. Angle Closure Glaucoma
        3. Other
        4. Prostaglandin Analog
        5. Beta Blockers
        6. Adrenergic Agonist
        7. Carbonic Anhydrase Inhibitors
        8. Others
        9. Hospital Pharmacy
        10. Retail Pharmacy
        11. Online Pharmacy
      8. Colombia
        1. Open Angle Glaucoma
        2. Angle Closure Glaucoma
        3. Other
        4. Prostaglandin Analog
        5. Beta Blockers
        6. Adrenergic Agonist
        7. Carbonic Anhydrase Inhibitors
        8. Others
        9. Hospital Pharmacy
        10. Retail Pharmacy
        11. Online Pharmacy
      9. Rest of LATAM
        1. Open Angle Glaucoma
        2. Angle Closure Glaucoma
        3. Other
        4. Prostaglandin Analog
        5. Beta Blockers
        6. Adrenergic Agonist
        7. Carbonic Anhydrase Inhibitors
        8. Others
        9. Hospital Pharmacy
        10. Retail Pharmacy
        11. Online Pharmacy
Report Details
−
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.